Literature DB >> 55736

Letter: Oral contraceptives and malignant hepatoma.

A B Glassberg, E H Rosenbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 55736     DOI： 10.1016/s0140-6736(76)91494-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Recurrent hepatic hemangiomas. Possible association with estrogen therapy.

Authors:  R L Conter; W P Longmire
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

2.  Does human liver contain estrogen receptors? A comparative study of estrogen binding in human and rodent liver.

Authors:  H Bojar; J Schütte; W Staib; C Broelsch
Journal:  Klin Wochenschr       Date:  1982-04-15

3.  Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasm.

Authors:  J S Macdonald; M E Lippman; P V Woolley; P P Petrucci; P S Schein
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 4.  Hepatobiliary complications of oral contraceptives.

Authors:  M C Lindberg
Journal:  J Gen Intern Med       Date:  1992 Mar-Apr       Impact factor: 5.128

5.  Fatal intraperitoneal haemorrhage of hepatic origin.

Authors:  A Fidas-Kamini; A Busuttil
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

6.  Hepatocellular carcinoma and oral contraceptives.

Authors:  B E Henderson; S Preston-Martin; H A Edmondson; R L Peters; M C Pike
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.